Caption Management’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$320K Buy
86,800
+26,700
+44% +$99.8K ﹤0.01% 1288
2025
Q4
$210K Sell
60,100
-700
-1% -$2.44K ﹤0.01% 1374
2025
Q3
$130K Buy
+60,800
New +$129K ﹤0.01% 1515
2024
Q4
Sell
-282,600
Closed -$350K 1443
2024
Q3
$350K Hold
282,600
0.01% 986
2024
Q2
$379K Hold
282,600
0.01% 863
2024
Q1
$384K Buy
282,600
+268,700
+1,933% +$572K 0.01% 919
2023
Q4
$36.4K Hold
13,900
﹤0.01% 1233
2023
Q3
$44.5K Buy
+13,900
New +$64.8K ﹤0.01% 1194

Other funds holding APYX

Caption Management's APYX Position: Q1 2026 in Review

Caption Management increased its Apyx Medical (APYX) stake by 16% in Q1 2026, buying an estimated $94.7K and bringing the position to 185,751 shares worth $685K. The position accounts for ﹤0.01% of the portfolio, ranked #1121.

Caption Management first reported a position in APYX in Q1 2019 and has held it in 12 quarters since. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Caption Management held 185,751 shares of Apyx Medical worth $685K as of Q1 2026.
  • Caption Management bought 25,344 Apyx Medical shares in Q1 2026, an estimated $94.7K.
  • Apyx Medical made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1121 holding.
  • Caption Management first reported a position in Apyx Medical in Q1 2019 and has held it in 12 quarters since.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.